ICER Publishes Cost-Effectiveness Study of Remdesivir for COVID-19 Patients
Researchers from the Institute for Clinical and Economic Review have published their cost-effectiveness analysis of remdesivir in the most recent [...]
ICER Revises 2018 Hereditary Angioedema Report Using RWE, Recommends Up to 75% Price Reduction
Researchers at the Institute for Clinical and Economic Review (ICER), Aetion, and the University of Washington collaborated to determine how [...]
Novartis and University of California-Berkeley Researchers Estimate $93 Billion Wasted Yearly Across Healthcare Stakeholders, Propose Value-Based Pricing System
Researchers at the University of California-Berkeley and Novartis note that $93 billion is wasted yearly in addressing healthcare utilization management, [...]
PHAR President and Health Economics Director Discuss the Inherent Racism in Cost-Effectiveness Analyses
PHAR President and Founder Dr. Michael Broder and Director of Health Economics Jesse Ortendahl shared their thoughts on how cost-effectiveness [...]
Register Today for Upcoming ISPOR Short Course on Applied Cost-Effectiveness Modeling with R
ISPOR will host a virtual short course on August 11th and 12th from 10:00 AM to 12:00 PM EDT. The [...]
ISPOR Value in Health Article Discusses Generating Cost-Effectiveness Analyses Using US Healthcare Data Based on Age and Disease
ISPOR’s Value in Health has published an article cataloguing healthcare costs and noting that cost-effectiveness analyses may allow for future [...]
Webinar on Value-Based Pricing Now Available On-Demand
Authors of a recently released book on drug pricing, The Right Price: A Value-Based Prescription for Drug Costs, hosted a webinar [...]
